ClinicalTrials.Veeva

Menu

Intraoperative Fentanyl Consumption Guided by Analgesia Nociception Index

K

Khon Kaen University

Status

Completed

Conditions

Postoperative Complications
Postoperative Pain

Treatments

Procedure: ANI protocol
Procedure: Standard protocol

Study type

Interventional

Funder types

Other

Identifiers

NCT03716453
HE611339

Details and patient eligibility

About

Balanced anesthesia needs optimization of hypnotic, relaxant, and narcotic. Administration of hypnotic drugs can be monitored by bispectral index score (BIS), while the dosage of muscle relaxants can be guided by train-of four (TOF). However, administration of narcotics lacks objective monitor. Overdosage of narcotic may lead to delayed awakening, while underdosage may lead to high degree of postoperative pain. Recently, there is a monitor, Analgesic Nociceptive Index (ANI) monitor, designed to guide the administration of narcotics. There are many descriptive studies supporting the correlation of ANI score and pain score but there are still very few randomized control studies which report the efficacy of ANI in clinical practice.

Full description

Objective: To evaluate the efficacy of ANI to guide the administration of intraoperative fentanyl.

Methods: Sixty female patients undergoing breast surgery with balanced anesthesia will be randomized into 2 groups. The first group will receive fentanyl according to standard practice of attending anesthesiologists. The second group will receive fentanyl according to ANI score protocol.

Primary outcome: Postoperative pain numeric rating scale (NRS) score during 60 minutes in postanesthetic care unit (PACU).

Secondary outcomes: Total intraoperative dose of fentanyl and postoperative nausea/vomiting and sedation score in PACU.

Enrollment

60 patients

Sex

Female

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults female undergoing elective breast surgery
  • American Society of Anesthesiologists (ASA) classification I-III
  • Body mass index (BMI) 18.5-35 kg/m2

Exclusion criteria

  • Implanted pacemaker
  • Cardiac arrythmia
  • Autonomic nervous system (ANS) disorder, e.g. epilepsy, stroke
  • Chronic opioid use
  • Chronic pain
  • On beta-blocker, calcium channel blocker, or other drugs to control arrythmia
  • Previous mastectomy
  • Pregnancy
  • On Nsaids

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups, including a placebo group

Control group
Placebo Comparator group
Description:
Intraoperative fentanyl administration will be guided by standard protocol
Treatment:
Procedure: Standard protocol
ANI group
Experimental group
Description:
Intraoperative fentanyl administration will be guided by ANI protocol
Treatment:
Procedure: ANI protocol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems